Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study

Virtually no clinical trials for smoking cessation have been undertaken in bipolar disorder. Varenicline has shown efficacy for smoking cessation, but warnings about neuropsychiatric adverse events have been issued. We assessed the efficacy and safety of varenicline in euthymic bipolar subjects moti...

Full description

Saved in:

Bibliographic Details
Published in:	The journal of clinical psychiatry Vol. 75; no. 7; p. 765
Main Authors:	Chengappa, K N Roy, Perkins, Kenneth A, Brar, Jaspreet S, Schlicht, Patricia J, Turkin, Scott R, Hetrick, Michelle L, Levine, Michele D, George, Tony P
Format:	Journal Article
Language:	English
Published:	United States 01.07.2014
Subjects:	Adult Benzazepines - administration & dosage Benzazepines - adverse effects Benzazepines - pharmacology Bipolar Disorder - drug therapy Bipolar Disorder - epidemiology Comorbidity Double-Blind Method Female Humans Male Middle Aged Nicotinic Agonists - administration & dosage Nicotinic Agonists - adverse effects Nicotinic Agonists - pharmacology Quinoxalines - administration & dosage Quinoxalines - adverse effects Quinoxalines - pharmacology Smoking - drug therapy Smoking - epidemiology Smoking Cessation - methods Treatment Outcome Varenicline
ISSN:	1555-2101, 1555-2101
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!